Advertisement
Canada markets open in 7 hours 44 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7320
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    83.50
    +0.14 (+0.17%)
     
  • Bitcoin CAD

    91,176.30
    +246.66 (+0.27%)
     
  • CMC Crypto 200

    1,439.47
    +24.71 (+1.75%)
     
  • GOLD FUTURES

    2,341.60
    -0.50 (-0.02%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0520 (-1.12%)
     
  • NASDAQ futures

    17,732.50
    +125.75 (+0.71%)
     
  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    38,418.83
    +866.67 (+2.31%)
     
  • CAD/EUR

    0.6836
    0.0000 (0.00%)
     

Pot Stocks & Biotech Stocks Trending In August 2018

CORAL GABLES, FL / ACCESSWIRE / August 15, 2018 / There is no lack of excitement this morning as trade tensions continue to loom during the pre-market hours. Turkey certainly has shifted a lot of the focus over the last 24 hours and many stocks are dipping during pre-market hours. There are, however, a number of other stocks that are making big moves after posting significant announcements this month. Today, in particular, there are 3 stocks that have attracted attention in the market.

GT Biopharma (GTBP) has been targeting key therapies in its pharmaceutical pipeline this year. Recent announcements that the company has a Material Transfer Agreement between a Major Pharmaceutical Company and Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics at the Masonic Cancer Center, University of Minnesota, has brought some attention to the company.

Though this ''Major Pharmaceutical Company'' has not been named yet, under the terms of the agreement, this Company will supply a formulation of their multibillion-dollar, widely prescribed oncology drug, which has been approved for use in several hematologic malignancies to Dr. Vallera to be used in this study. Initial pre-clinical work performed by Dr. Vallera suggests a much greater effect when OXS-1550 is given in combination with this established oncology drug.

GT Biopharma's Chief Executive Officer, Dr. Raymond W. Urbanski, will be presenting at the Wedbush PacGrow Healthcare Conference today and will provide a corporate overview as well as highlight the company's proprietary technology platforms.

ADVERTISEMENT

More information On GT Biopharma, Click Here

Canopy Growth (CGC) (WEED.TO) is having a banner day after it was announced that Constellation Brands (STZ) is upping its bet on the cannabis industry, announcing an additional $4 billion stake in Canopy Growth on Wednesday.

"Over the past year, we've come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy's market-leading capabilities in this space," Constellation Brands CEO Rob Sands said in a statement.

Pre-market saw the stock hitting highs of $40 per share.

More information On Canopy, Click Here

Staffing 360 Solutions, Inc. (STAF) is set for a green open after the company reported second-quarter results on Wednesday morning. Revenue grew by 42% to $59.7 million, gross profit grew by 50% to $11.9 million, and gross margin strengthened to 19.9%.

Brendan Flood, Chairman, and Chief Executive Officer stated, ''Q2 2018 was another record revenue quarter for STAF 360 and continued the validation of our strategy. We experienced an increase in the number of temporary contractors deployed and a higher number of temporary contractor hours billed; while at the same time saw strength in the permanent placement business.''

Staffing 360 reached morning highs of $3.48 on Wednesday.

For More Information On Staffing 360 Solutions, Click Here.

About marijuanastocks.com

MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Contact Information:

pr@marijuanastocks.com

SOURCE: MarijuanaStocks.com